Repsol To Sell Stake In Gas Natural For €3.82 Bln

Repsol SA REP said Thursday that it has reached an agreement to sell its 20% stake in Gas Natural SDG SA (GAS.MC) to CVC Capital Partners for EUR3.82 billion euros ($4.7 billion), or EUR19 a share.

Repsol said that the consolidated capital gain from the transaction, which completes its divestment from Gas Natural, will amount to about EUR400 million.

The deal is subject to a shareholder's agreement between CVC and Gas Natural's other two big shareholders--CriteriaCaixa and Global Infrastructure Partners, or GIP, Repsol said. It is also subject to regulatory approvals, Repsol added. Under the terms of the deal, CVC will appoint three members to the board, replacing the Repsol-designated ones, Repsol said.

The transaction follows a similar operation in 2016, when Repsol and CriteriaCaixa each sold a 10% stake to GIP at 19 euros a share.

Once this transaction is completed, Gas Natural's biggest shareholders will be CriteriaCaixa--with a 24% stake--and CVC and GIP, each with 20% interests.

Repsol had confirmed in January CVC's interest in its Gas Natural stake, responding to media speculation over a possible sale.

RECENT NEWS

Gyrostat Capital Management: The Hidden Architecture Of Consequences

When Structures Themselves Become A Risk In portfolio construction, risk is rarely where we look for it.... Read more

Gyrostat November Outlook: The Rising Cost Of Doing Nothing

Through the second half of 2025, markets have delivered a curious mix of surface tranquillity and instabi... Read more

Gyrostat Capital Management: Blending Managers - From Style Diversification To Scenario Diversification

The Limits of Traditional Diversification For decades, portfolio construction has ... Read more

Gyrostat October Outlook: Beneath The Calm, The Cost Of Protection Rises

 Even as global equity indices remain near record highs, the pricing of risk is shifting quietly ben... Read more

Gyrostat Capital Management: Solving The Nastiest Problem In Finance

Retirement Income and Sequencing Risk Executive Summary ... Read more